Investor's Business Daily on MSN
Arrowhead says its gene silencer doubled Zepbound's weight loss
Arrowhead Pharmaceuticals said Tuesday its gene-silencing approach almost doubled the four-month weight-loss with tirzepatide ...
Arrowhead Pharmaceuticals has reported early-phase data on a pair of gene silencing drug candidates in obesity, posting ...
Arrowhead Pharmaceuticals has received authorisation from Health Canada for its small interfering RNA (siRNA) medicine, ...
KANSAS CITY, Mo. (KCTV) - The Kansas City Chiefs have called Arrowhead Stadium their home since 1972. Here’s an in-depth look ...
The Kansas City Chiefs will leave Arrowhead Stadium after the 2030 season and open a new domed venue in Kansas for 2031.
Investing.com -- Arrowhead Pharmaceuticals (NASDAQ:ARWR) stock surged 16% after the company announced promising interim clinical data for its RNAi-based obesity treatments that showed significant ...
All eyes were on the star tight end throughout what some are speculating could have been his last home game in KC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback